Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOOKAD Soluble vs Active Surveillance in Low-Risk Prostate Cancer
NCT01310894Phase 3Completed
- Sponsor
- Steba Biotech
- Start
- Feb 2011
- Primary completion
- Jun 2015
- Modality
- Light/Condition-Responsive Prodrugs
- Countries
- 10
01
Overview
A Phase 3 trial of padeliporfin VTP in prostate cancer (PCa), sponsored by Steba Biotech. Started Feb 2011; status: completed.
02
Drugs
padeliporfin VTP
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01310894.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01310894.